Navigation Links
BioCryst to Present at UBS 2008 Global Life Sciences Conference
Date:9/16/2008

our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors that could affect the forward-looking statements contained herein include that our belief that many subjects in the Phase II clinical trials of peramivir did not receive adequate dosing by intramuscular injection may not be correct, that HHS and the Food & Drug Administration (FDA) may not agree with our analysis, that HHS may further condition, reduce or eliminate future funding of the peramivir program, that ongoing peramivir clinical trials may not be successful, that the peramivir program may not be successful, that the pivotal trial with forodesine HCl in cutaneous T-cell lymphoma (CTCL) may not meet its endpoint, that the Phase II trial of BCX-4208 for psoriasis may not be successfully completed, that development and commercialization of forodesine HCl in CTCL may not be successful, that we or our licensees may not be able to enroll the required number of subjects in planned clinical trials of our product candidates and that such clinical trials may not be successfully completed, that BioCryst or its licensees may not commence as expected additional human clinical trials with our product candidates, that our product candidates may not receive required regulatory clearances from the FDA, that ongoing and future preclinical and clinical development may not have positive results, that we or our licensees may not be able to continue future development of our current and future development programs, that our development programs may never result in future product, license or royalty payments being received by BioCryst, that B
'/>"/>
SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008
2. William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
3. BioCryst Reports First Quarter 2008 Financial Results and Clinical Update
4. BioCryst Reports Fourth Quarter and Year End 2007 Financial Results and Corporate Update
5. BioCryst Pharmaceuticals to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on March 4, 2008
6. BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities
7. BioCryst to Present at UBS 2007 Global Life Sciences Conference
8. BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza
9. BioCryst to Present at the BioCentury NewsMakers in the Biotech Industry Conference
10. Symmetry Medical to Present at UBS Global Life Sciences Conference
11. Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... Caustic soda is utilized in the production of zeolites, sodium ... lead in the global caustic soda market, followed by the ... in the USA, Germany, Brazil and Canada, is currently the ... of output and production capacities. , The global caustic soda ... year in the years ahead. The APAC region is the ...
(Date:10/31/2014)... (PRWEB) October 30, 2014 The ... Product Development’s decades-long heritage in successful medical device ... context for what it takes to successfully innovate ... As part of a two-hour on-site class, Insight ... school of business, McCormick School of Engineering, medical ...
(Date:10/31/2014)... October 30, 2014 Two separate ... were hosted by Charm Sciences at its Andover, ... week in the US, the participants discussed international ... hygiene management, and process verification, and received hands-on ... This was the first visit to the United ...
(Date:10/31/2014)... Ill. (PRWEB) October 31, 2014 Jeffrey ... Department of Historical Studies within the College of Arts ... SIUE to record the history of alcohol-based fuels in ... and many others have been working to build Illinois’ ... important but overlooked aspect of the state's agricultural and ...
Breaking Biology Technology:China to Dominate Caustic Soda Market Through 2018, Says Merchant Research & Consulting in Its New Study 2Insight Product Development Gives Northwestern University Students Foundation for Innovation Success 2Insight Product Development Gives Northwestern University Students Foundation for Innovation Success 3Charm Sciences Hosts Executives from Latin America for Dairy Safety Executive Seminar 2SIUE History Prof Manuel Working on Biofuels Book with NCERC 2SIUE History Prof Manuel Working on Biofuels Book with NCERC 3
... The inaugural  European Neurotech Investing & Partnering ... keynotes on the state of the European neurotech industry, investor ... next generation treatments emerging in the EU for unmet needs ... , s, addiction, depression, schizophrenia, Parkinson , ...
... it,s at the farthest end of the far infrared ... the airport to designing drugs to diagnosing skin cancer. Now, ... Energy,s Lawrence Berkeley National Laboratory (Berkeley Lab) and the University ... of graphene the remarkable form of carbon that,s only ...
... PLAINFIELD, N.J. and CAMBRIDGE, Mass.,  Sept. 2, 2011 ... company, announced today the restructuring of their collaboration. ... for the U.S. and Canada and Genzyme held ... restructured agreement, PTC regains worldwide rights to ataluren ...
Cached Biology Technology:High-Level Neurotech Summit Brings Companies, Researchers and Investors Together in Helsinki 2High-Level Neurotech Summit Brings Companies, Researchers and Investors Together in Helsinki 3A whole new light on graphene metamaterials 2A whole new light on graphene metamaterials 3PTC Therapeutics and Genzyme Announce Restructuring of Collaboration 2PTC Therapeutics and Genzyme Announce Restructuring of Collaboration 3
(Date:10/31/2014)... has developed a new test that can distinguish between ... of avian influenza virus or "bird flu" with those ... significant step in the fight against this often fatal ... poultry populations of South East Asia, particularly Indonesia and ... possible transmission to humans and the threat of a ...
(Date:10/30/2014)... a $1.04 million grant from the U.S. Army ... osteoarthritis using a patient,s own stem cells, spurred ... polymers., Liping Tang, a bioengineering professor and interim ... is primarily focused on helping soldiers who are ... if we inject microscaffolding that we,ve developed into ...
(Date:10/30/2014)... 2014 – Bacteria in the gastrointestinal tract fulfill ... Yet, these same bacteria can induce strong inflammatory ... the gut and enter the bloodstream. , Although ... the body, chronic or systemic inflammation is linked ... established the involvement of inflammatory processes in the ...
Breaking Biology News(10 mins):New step towards eradication of H5N1 bird flu 2UTA researcher uses microscaffolding injections to mend cartilage, prevent osteoarthritis 2Breakdown in gut barriers to bacteria may promote inflammation and craving in alcoholics 2
... Mainz (JGU) in Germany have discovered that tiny vanadium ... and algae on surfaces in contact with water, such ... experiments showed that steel plates to which a coating ... be exposed to seawater for weeks without the formation ...
... Research Hospital scientists has identified a possible new approach ... system component in a bid to invigorate the immune ... primary function of one of the innate immune molecules ... immune response to infections and other threats. Investigators showed ...
... species of phorid fly from Thailand is the smallest fly ever ... smaller than a house fly and five times smaller than a ... also the first of its genus to be discovered in Asia, ... for "decapitating" ants. Some species in the Phoridae fly family ...
Cached Biology News:Paints and coatings containing bactericidal agent nanoparticles combat marine fouling 2Paints and coatings containing bactericidal agent nanoparticles combat marine fouling 3Innate immune system protein provides a new target in war against bacterial infections 2Innate immune system protein provides a new target in war against bacterial infections 3
Screening test for the detection of Salmonella sp. by means of DNA amplification, subsequent molecular hybridization and detection on a microtitre plate....
... Application: The simple three step procedure ... can be completed in one day. The ... greater than 80%. , Features and Benefits: ... be cloned into any expression vector , ...
... 96- or 384-well PCR plates Dimples on both ... 96-tube plates End tabs on Thermo-Mat™ 384 fit ... Efficient sealing is achieved with either Thermo-Mat™ 96 or ... hot lid thermal cyclers Fully autoclavable ...
... Streptavidin-HRP Systems provide rapid, precise localization ... in frozen or paraffin-embedded tissue, cytospins ... also facilitate double or triple labeleing ... simultaneously with primary antibodies of different ...
Biology Products: